The CannabCo Pharmaceutical Company (CannabCo), situated in Brampton, Ontario, introduced on Tuesday an settlement with an unspecified expertise supplier to launch an superior cannabis expertise for the manufacturing of near-odorless cannabis.

CannabCo COO Mark Novak says that cannabis smoke is often very heavy and may trigger coughing, notably for much less skilled customers.

The brand new expertise, dubbed PURECANN, was initially developed for the medical cannabis market and designed to remove any harshness from smoking with out shedding different properties.

“Over the past two years we’ve noticed product being processed with the system and we got the chance to supply suggestions and recommendations for the refinement course of,” mentioned Novak. “We now have been extremely happy with the outcomes. In utilizing this expertise CannabCo will be capable of produce all kinds of merchandise at present not within the market, addressing a key market section that doesn’t exist.”

In line with CannabCo, dry cannabis processed with PURECANN expertise is much less harsh, smokes smoother, and has nearly no odor when being saved or smoked,

CannabCo additionally says that PURECANN cannabis additionally leaves the person with much less residual day-after results generally related to smoking marijuana.

“Once we noticed the expertise in motion and the tip end result, we realized there have been plenty of potential markets related to the usage of PURECANN,” mentioned CannabCo President and CEO Mark Pellicane. “There are not any third-party devices, or gadgets on the a part of the person, the tip result’s pure cannabis that doesn’t scent.”

As soon as CannabCo has obtained the correct license from Well being Canada, the corporate may have unique rights to make use of the PURECANN expertise in manufacturing for each medical and adult-use markets.